Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies

NeuroImage: Clinical

Volumn 7, Issue , 2015, Pages 456-462

  Mak, Elijah ^a   Su, Li ^a   Williams, Guy B ^b   Watson, Rosie ^c,d   Firbank, Michael ^d   Blamire, Andrew M ^d   O'Brien, John T ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Atrophy; Dementia; Lewy bodies; Neuroimaging

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PRIORITY JOURNAL; TEMPORAL LOBE; UNIFIED PARKINSON DISEASE RATING SCALE; ATROPHY; BRAIN; COMPUTER ASSISTED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; LEWY BODY DISEASE; PATHOLOGY;

AGED; ALZHEIMER DISEASE; ATROPHY; BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84922462177     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2015.01.017     Document Type: Article

References (40)

1. Ballmaier M.; O'Brien J.T.; Burton E.J.; Thompson P.M.; Rex D.E.; Narr K.L.; McKeith I.G.; DeLuca H.; and Toga A.W. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects Neuroimage 23 1 2004 325 335 10.1016/j.neuroimage.2004.04.026 15325380
2. Bartsch A.J.; De Stefano N.; Homola G.; and Smith S. Extending SIENA for a multi-subject statistical analysis of sample-specific cerebral edge shifts: substantiation of early brain regeneration through abstinence from alcoholism Tenth Int. Conf. Funct. Mapp. Hum. Brain 2004
3. Bradley K.M.; Bydder G.M.; Budge M.M.; Hajnal J.V.; White S.J.; Ripley B.D.; and Smith A.D. Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease Br. J. Radiol. 75 894 2002 506 513 12124237
4. Burton E.J.; Barber R.; Mukaetova-Ladinska E.B.; Robson J.; Perry R.H.; Jaros E.; Kalaria R.N.; and O'Brien J.T. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis Brain 132 1 2009 195 203 10.1093/brain/awn298 19022858
5. Burton E.J.; Karas G.; Paling S.M.; Barber R.; Williams E.D.; Ballard C.G.; McKeith I.G.; Scheltens P.; Barkhof F.; and O'Brien J.T. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry Neuroimage 17 2 2002 618 630 10.1006/nimg.2002.1197 12377138
6. Burton E.J.; McKeith I.G.; Burn D.J.; and O'Brien J.T. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging Mov. Disord. 20 12 2005 1571 1576 10.1002/mds.20652 16116613
7. Cover K.S.; van Schijndel R.A.; van Dijk B.W.; Redolfi A.; Knol D.L.; Frisoni G.B.; Barkhof F.; Vrenken H. neuGRID Alzheimer's Disease Neuroimaging Initiative Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-RAGE MRI scans Psychiatry Res. 193 3 2011 182 190 10.1016/j.pscychresns.2011.02.012 21764565
8. Cummings J.L.; Mega M.; Gray K.; Rosenberg-Thompson S.; Carusi D.A.; and Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia Neurology 44 12 1994 2308 2314 7991117
9. Fjell A.M.; Walhovd K.B.; Fennema-Notestine C.; McEvoy L.K.; Hagler D.J.; Holland D.; Brewer J.B.; and Dale A.M. One-year brain atrophy evident in healthy aging J. Neurosci. 29 48 2009 15223 15231 10.1523/JNEUROSCI.3252-09.2009 19955375
10. Folstein M.F.; Folstein S.E.; and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res. 12 3 1975 189 198 1202204
11. Fox N.C.; Crum W.R.; Scahill R.I.; Stevens J.M.; Janssen J.C.; and Rossor M.N. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images Lancet 358 9277 2001 201 205 10.1016/S0140-6736(01)05408-3 11476837
12. Fox N.C.; and Freeborough P.A. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease J. Magn. Reson. Imaging 7 6 1997 1069 1075 9400851
13. Frisoni G.B.; Fox N.C.; Jack C.R.; Scheltens P.; and Thompson P.M. The clinical use of structural MRI in Alzheimer disease Nat. Rev. Neurol. 6 2 2010 67 77 20139996
14. Henneman W.J.; Sluimer J.D.; Barnes J.; van der Flier W.M.; Sluimer I.C.; Fox N.C.; Scheltens P.; Vrenken H.; and Barkhof F. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures Neurology 72 11 2009 999 1007 10.1212/01.wnl.0000344568.09360.31 19289740
15. Huppert F.A.; Brayne C.; Gill C.; Paykel E.S.; and Beardsall L. CAMCOG - a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample Br. J. Clin. Psychol. 34 4 1995 529 541
16. Jenkinson M.; and Smith S. A global optimisation method for robust affine registration of brain images Med. Image Anal. 5 2 2001 143 156 11516708
17. Lashuel H.A.; Overk C.R.; Oueslati A.; and Masliah E. The many faces of α-synuclein: from structure and toxicity to therapeutic target Nat. Rev. Neurosci. 14 1 2013 38 48 10.1038/nrn3406 23254192
18. Mak E.; Su L.; Williams G.B.; and O'Brien J.T. Neuroimaging characteristics of dementia with Lewy bodies Alzheimers Res. Ther. 6 2 2014 18 25031634
19. Marshall G.A.; Fairbanks L.A.; Tekin S.; Vinters H.V.; and Cummings J.L. Early-onset Alzheimer's disease is associated with greater pathologic burden J. Geriatr. Psychiatry Neurol. 20 1 2007 29 33 10.1177/0891988706297086 17341768
20. McKeith I.G.; Ballard C.G.; Perry R.H.; Ince P.G.; O'Brien J.T.; Neill D.; Lowery K.; Jaros E.; Barber R.; Thompson P.; Swann A.; Fairbairn A.F.; and Perry E.K. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies Neurology 54 5 2000 1050 1058 10720273
21. McKeith I.G.; Dickson D.W.; Lowe J.; Emre M.; O'Brien J.T.; Feldman H.; Cummings J.; Duda J.E.; Lippa C.; Perry E.K.; Aarsland D.; Arai H.; Ballard C.G.; Boeve B.; Burn D.J.; Costa D.; Del Ser T.; Dubois B.; Galasko D.; Gauthier S.; Goetz C.G.; Gomez-Tortosa E.; Halliday G.; Hansen L.A.; Hardy J.; Iwatsubo T.; Kalaria R.N.; Kaufer D.; Kenny R.A.; Korczyn A.; Kosaka K.; Lee V.M.; Lees A.; Litvan I.; Londos E.; Lopez O.L.; Minoshima S.; Mizuno Y.; Molina J.A.; Mukaetova-Ladinska E.B.; Pasquier F.; Perry R.H.; Schulz J.B.; Trojanowski J.Q.; and Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Neurology 65 12 2005 1863 1872 10.1212/01.wnl.0000187889.17253.b1 16237129
22. McKeith I.G.; Galasko D.; Kosaka K.; Perry E.K.; Dickson D.W.; Hansen L.A.; Salmon D.P.; Lowe J.; Mirra S.S.; Byrne E.J.; Lennox G.; Quinn N.P.; Edwardson J.A.; Ince P.G.; Bergeron C.; Burns A.; Miller B.L.; Lovestone S.; Collerton D.; Jansen E.N.; Ballard C.; de Vos R.A.; Wilcock G.K.; Jellinger K.A.; and Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop Neuroil. 47 5 1996 1113 1124 8909416
23. McKhann G.; Drachman D.; Folstein M.; Katzman R.; Price D.; and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neuroil. 34 7 1984 939 944 10.1212/wnl.34.7.939 6610841
24. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations Mov. Disord. 18 7 2003 738 750 10.1002/mds.10473 12815652
25. Nelson P.T.; Schmitt F.A.; Jicha G.A.; Kryscio R.J.; Abner E.L.; Smith C.D.; Van Eldik L.J.; and Markesbery W.R. Association between male gender and cortical Lewy body pathology in large autopsy series J. Neurol. 257 11 2010 1875 1881 10.1007/s00415-010-5630-4 20563821
26. Nichols T.E.; and Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples Hum. Brain Mapp. 15 1 2002 1 25 11747097
27. O'Brien J.T.; Paling S.; Barber R.; Williams E.D.; Ballard C.; McKeith I.G.; Gholkar A.; Crum W.R.; Rossor M.N.; and Fox N.C. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia Neurology 56 10 2001 1386 1388 11376193
28. Schott J.M.; Price S.L.; Frost C.; Whitwell J.L.; Rossor M.N.; and Fox N.C. Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months Neurology 65 1 2005 119 124 10.1212/01.wnl.0000167542.89697.0f 16009896
29. Sluimer J.D.; van der Flier W.M.; Karas G.B.; Fox N.C.; Scheltens P.; Barkhof F.; and Vrenken H. Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients Radiology 248 2 2008 590 598 10.1148/radiol.2482070938 18574133
30. Smith S.M.; De Stefano N.; Jenkinson M.; and Matthews P.M. Normalized accurate measurement of longitudinal brain change J. Comput. Assist. Tomogr. 25 3 2001 466 475 11351200
31. Smith S.M.; Rao A.; De Stefano N.; Jenkinson M.; Schott J.M.; Matthews P.M.; and Fox N.C. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX Neuroimage 36 4 2007 1200 1206 10.1016/j.neuroimage.2007.04.035 17537648
32. Smith S.M.; Zhang Y.; Jenkinson M.; Chen J.; Matthews P.M.; Federico A.; and De Stefano N. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis Neuroimage 17 1 2002 479 489 12482100
33. Stricker N.H.; Chang Y.-L.; Fennema-Notestine C.; Delano-Wood L.; Salmon D.P.; Bondi M.W.; Dale A.M. Alzheimer's Disease Neuroimaging Initiative Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease Neuroil. 77 8 2011 713 721 10.1212/WNL.0b013e31822b0004 21832223
34. Walker M.P.; Ayre G.A.; Cummings J.L.; Wesnes K.; McKeith I.G.; O'Brien J.T.; and Ballard C.G. The clinician assessment of fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia Br. J. Psychiatry 177 2000 252 256 11040887
35. Watson R.; Blamire A.M.; Colloby S.J.; Wood J.S.; Barber R.; He J.; and O'Brien J.T. Characterizing dementia with Lewy bodies by means of diffusion tensor imaging Neurology 79 9 2012 906 914 10.1212/WNL.0b013e318266fc51 22895591
36. Watson R.; O'Brien J.T.; Barber R.; and Blamire A.M. Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study Int. Psychogeriatr. 24 4 2012 532 540 10.1017/s1041610211002171 22126938
37. Whitwell J.L.; Jack C.R. Jr.; Parisi J.E.; Knopman D.S.; Boeve B.F.; Petersen R.C.; Ferman T.J.; Dickson D.W.; and Josephs K.A. Rates of cerebral atrophy differ in different degenerative pathologies Brain 130 4 2007 1148 1158 10.1093/brain/awm021 17347250
38. Williams M.M.; Xiong C.; Morris J.C.; and Galvin J.E. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease Neurology 67 11 2006 1935 1941 10.1212/01.wnl.0000247041.63081.98 17159097
39. Wolozin B.; and Behl C. Mechanisms of neurodegenerative disorders: part 1: protein aggregates Arch. Neurol. 57 6 2000 793 796 10.1001/archneur.57.6.793 10867775
40. Zhang Y.; Brady M.; and Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm IEEE Trans. Med. Imaging 20 1 2001 45 57 10.1109/42.906424 11293691